Evaluation of Microinvasive Glaucoma Surgery: MINIject® Versus Hydrus® Microstent in Combination With Cataract Surgery

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The study aims to investigate postoperative outcomes after two different MIGS implants (MINIject or Hydrus) in combination with cataract surgery for patients with glaucoma.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with glaucoma in which surgery is indicated to reach target intraocular pressure as well as lens opacities where CS is indicated

• Clinically eligible for both surgeries

• Subjects not anticipated to require any further surgery in the next 12 months

• Patients' age \> 18 years

Locations
Other Locations
Austria
Medical University Graz
RECRUITING
Graz
Contact Information
Primary
Ewald Lindner, Prof.
ewald.lindner@medunigraz.at
+4331638580810
Backup
Lena M Haiden, MD
lena.haiden@medunigraz.at
+4331638530798
Time Frame
Start Date: 2025-03-03
Estimated Completion Date: 2031-03-03
Participants
Target number of participants: 152
Treatments
Active_comparator: MINIject
MINIject with Cataract Surgery
Active_comparator: Hydrus Microstent
Hydrus Microstent with Cataract Surgery
Sponsors
Leads: Medical University of Graz

This content was sourced from clinicaltrials.gov